Inventor
BICKEL MARTIN
DE67 patents
⚠️ This page may combine multiple inventors who share the name “BICKEL MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOECHST AG
27 patentsUS5719164AFeb 17, 1998
Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
HOECHST AG145 citations99
US6020350AFeb 1, 2000
3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals
HOECHST AG95 citations98
US5658933AAug 19, 1997
Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
HOECHST AG143 citations98
US5620995AApr 15, 1997
Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals
HOECHST AG165 citations98
US5726305AMar 10, 1998
Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
HOECHST AG91 citations96
US5620996AApr 15, 1997
Sulfonamidocarbonyl pyridine-2-carboxesteramides and their pyridine-N-oxide compounds and their use as pharmaceuticals
HOECHST AG64 citations95
US5610172AMar 11, 1997
Sulfonamidocarbonylpyridine-2-carboxamides and pyridine-n-oxides which are useful as pharmaceuticals
HOECHST AG80 citations95
US5607954AMar 4, 1997
Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
HOECHST AG72 citations95
US5519038AMay 21, 1996
N,N'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamines
HOECHST AG21 citations92
US5260323ANov 9, 1993
2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use
HOECHST AG54 citations92
US5130317AJul 14, 1992
Pyrimidine-4,6-dicarboxylic acid diamides, processes for the use thereof, and pharmaceuticals based on these compounds
HOECHST AG32 citations92
US4258057AMar 24, 1981
Prostaglandin derivatives of the Δ2,4-11-deoxy-PEG series
HOECHST AG19 citations82
US5786365AJul 28, 1998
Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith
HOECHST AG15 citations74
US4661636AApr 28, 1987
6-sulfoxyphenol derivatives, their preparation and their use as cytoprotective agents
HOECHST AG11 citations74
US5356909AOct 18, 1994
Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
HOECHST AG5 citations73
US5037839AAug 6, 1991
Pyridine-2,4-and -2,5-dicarboxylic acid amides and medicaments based on these compounds
HOECHST AG15 citations73
US5004748AApr 2, 1991
Substituted pyridine-2,4-dicarboxylic acid derivatives and medicaments based on these compounds
HOECHST AG5 citations73
US4302448ANov 24, 1981
Secretin preparations with intensified and protracted action, process for their manufacture, their use as well as dihydroxybenzoyl-L-tyrosine
HOECHST AG13 citations72
US5130310AJul 14, 1992
Substituted benzo[b]pyrans, processes for their preparation, their use and pharmaceutical preparations based on these compounds
HOECHST AG10 citations70
US5512586AApr 30, 1996
Medicaments based on pyridine-2,4- and 2,5-dicarboxylic acid amides
HOECHST AG2 citations62
US5153208AOct 6, 1992
Pyridine-2,4- and -2,5-dicarboxylic acid amides and their medicinal compositions and methods of use
HOECHST AG4 citations62
US5143926ASep 1, 1992
Substituted pyridine-2,4-dicarboxylic acid compounds and methods of use thereof
HOECHST AG4 citations62
US4459225AJul 10, 1984
Peptide amides and process for their manufacture
HOECHST AG2 citations62
US4585775AApr 29, 1986
Substituted pyrido (1,2-c)imidazo(1,2-a)benzimidazoles, processes for their preparation, their use and pharmaceutical preparations based on these compounds
HOECHST AG2 citations61
US5364873ANov 15, 1994
Pyridine-2,4- and dicarboxylic acid derivatives, the use thereof and pharmaceutical composition based on these compounds
HOECHST AG2 citations59
US5863901AJan 26, 1999
Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders
HOECHST AG1 citations52
US5428046AJun 27, 1995
Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine N-oxides, processes for their preparation and their use as medicaments
HOECHST AG2 citations52
AVENTIS PHARMA GMBH
18 patentsUS6476059B1Nov 5, 2002
Use of polycyclic 2-aminothiazole systems for the treatment of obesity
AVENTIS PHARMA GMBH29 citations93
US6251922B1Jun 26, 2001
Polycyclic 2- aminothiazole systems, processes for their preparation and pharmaceuticals comprising these compounds
AVENTIS PHARMA GMBH29 citations92
US6717008B2Apr 6, 2004
Derivatives of C2-substituted indan-1-ol compounds, methods for their preparation and use
AVENTIS PHARMA GMBH13 citations84
US6187801B1Feb 13, 2001
Polycyclic thiazole systems, processes for their preparation and pharmaceuticals comprising these compounds
AVENTIS PHARMA GMBH20 citations83
US6686397B2Feb 3, 2004
Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
AVENTIS PHARMA GMBH8 citations74
US6339077B1Jan 15, 2002
Substituted 4-benzylaminoquinolines and their hetero analogs, process for their preparation, pharmaceuticals containing these compounds and use thereof
AVENTIS PHARMA GMBH8 citations74
US7015208B2Mar 21, 2006
C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
AVENTIS PHARMA GMBH2 citations63
US6667345B2Dec 23, 2003
Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity
AVENTIS PHARMA GMBH3 citations63
US6235763B1May 22, 2001
Polycyclic 2-aminodihydrothiazole systems, processes for their preparation and their use as pharmaceuticals
AVENTIS PHARMA GMBH6 citations63
US7045649B2May 16, 2006
C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
AVENTIS PHARMA GMBH0 citations52
US6919380B2Jul 19, 2005
Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity
AVENTIS PHARMA GMBH0 citations52
US6812257B2Nov 2, 2004
Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
AVENTIS PHARMA GMBH0 citations52
US6812256B2Nov 2, 2004
Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
AVENTIS PHARMA GMBH0 citations52
US6670401B2Dec 30, 2003
Polysubstituted indan-1-ol compounds, and methods for their preparation and use
AVENTIS PHARMA GMBH2 citations52
US6657086B2Dec 2, 2003
C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
AVENTIS PHARMA GMBH0 citations52
US6444669B1Sep 3, 2002
8,8a-dihydroindeno[1,2-d]thiazole derivatives which carry in the 2-position a substituent having a sulfonamide structure or sulfone structure; processes for their preparation and their use as medicaments
AVENTIS PHARMA GMBH1 citations52
US6352987B2Mar 5, 2002
8,8a-dihydroindeno[1,2-d]thiazole derivatives which carry in the 2-position a substituent having a sulfonamide structure or sulfone structure; processes for their preparation and their use as medicaments
AVENTIS PHARMA GMBH0 citations52
US6291486B1Sep 18, 2001
Polycyclic Dihydrothiazoles, their preparation and use as pharmaceuticals
AVENTIS PHARMA GMBH0 citations52
SANOFI AVENTIS DEUTSCHLAND
2 patentsUS7820804B2Oct 26, 2010
Fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
SANOFI AVENTIS DEUTSCHLAND6 citations60
US7763662B2Jul 27, 2010
Use of C2-substituted indan-1-ol systems for preparing medicaments for the prophylaxis or treatment of obesity
SANOFI AVENTIS DEUTSCHLAND1 citations52
AVENTISPHARMA DEUTSCHLAND GMBH
1 patentMAN TECHNOLOGIE GMBH
1 patentAVENTIS PHARMA DEUTSCHAND GMBH
1 patentShowing the top 50 of 67 patents by PatentIndex Score.